The successful preparation of two-dimensional (2D) single crystals can promote the development of organic optoelectronic devices with excellent performance. A Schiff base compound ...

Treatment consisted of oral decitabine 35 mg plus cedazuridine 100 mg on days 1–5 and venetoclax (variable doses of 100–400 mg, day 1 to 14, 28-day cycle). The primary outcomes were safety for the ...